Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | ACRS Aclaris Therapeutics, Inc. | 13G/A | 2.5% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | ELEV Elevation Oncology, Inc. Common stock | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Sotirios J. Vahaviolos | MG Mistras Group, Inc. | 13G/A | 6% | Dec 31, 2023 | 2y |
| Westchester Capital Management, LLC | VMCAF Valuence Merger Corp. I | 13G | 9.94% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners II, L.P. | LYRA Lyra Therapeutics, Inc. | 13G/A | 10% | Dec 31, 2023 | 2y |
| G1 Execution Services, LLC | MSTR Strategy Inc | 13G/A | 6.1% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | HONE HarborOne Bancorp, Inc. Common Stock | 13G | 12.5% | Dec 31, 2023 | 2y |
| Stephen Fredette | TOST Toast, Inc. | 13G/A | 7% | Dec 31, 2023 | 2y |
| BECK MACK & OLIVER LLC | CWGL Crimson Wine Group, Ltd | 13G/A | 8.7% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | PLAO Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares | 13G/A | 5.04% | Dec 31, 2023 | 2y |
| Westchester Capital Management, LLC | CNGL Canna-Global Acquisition Corp. Class A Common Stock | 13G/A | 1.36% | Dec 31, 2023 | 2y |
| SOFTBANK GROUP CORP. | BABA Alibaba Group Holding Ltd | 13G/A | 14% | Dec 31, 2023 | 2y |
| Alexandria Real Estate Equities, Inc. | APLT Applied Therapeutics, Inc. Common Stock | 13G/A | 15.4% | Dec 31, 2023 | 2y |
| ArrowMark Colorado Holdings LLC | CMPR CIMPRESS plc | 13G/A | 5.13% | Dec 31, 2023 | 2y |
| ARISTEIA CAPITAL, L.L.C. | LBRDK Liberty Broadband Corp | 13G/A | 8.49% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | PEN Penumbra Inc | 13G | 8% | Dec 31, 2023 | 2y |
| EVERGREEN CAPITAL MANAGEMENT LLC | TEI Templeton Emerging Markets Income Fund | 13G/A | 6.5% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | SMTC Semtech Corp | 13G/A | 2.6% | Dec 31, 2023 | 2y |
| Rock Springs Capital Management LP | SYRE Spyre Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| VIKING GLOBAL INVESTORS LP | FIVN Five9, Inc. | 13G/A | 3.7% | Dec 31, 2023 | 2y |
| Calamos Market Neutral Income Fund, a series of Calamos Investment Trust | SGHL Signal Hill Acquisition Corp. Class A Common Stock | 13G | 0% | Dec 31, 2023 | 2y |
| Fourthstone LLC | PBAM Private Bancorp of America, Inc. | 13G/A | 9.95% | Dec 31, 2023 | 2y |
| DRAKE FRED L | HBT HBT Financial, Inc. | 13G/A | 54.7% | Dec 31, 2023 | 2y |
| COHEN & STEERS, INC. | JLL Jones Lang Lasalle Inc | 13G/A | 0% | Dec 31, 2023 | 2y |
| RGM Capital, LLC | PRO Pros Holdings, Inc. | 13G/A | 6.06% | Dec 31, 2023 | 2y |
| Jericho Capital Asset Management L.P. | SPHR Sphere Entertainment Co. | 13G | 8.6% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | VRAX Virax Biolabs Group Ltd | 13G | 9.99% | Dec 31, 2023 | 2y |
| Select Equity Group, L.P. | MORN Morningstar, Inc. | 13G/A | 7% | Dec 31, 2023 | 2y |
| James K. Sims | AIRG Airgain Inc | 13G/A | 6.5% | Dec 31, 2023 | 2y |
| Long Focus Capital Management, LLC | ADAPY Adaptimmune Therapeutics PLC | 13G/A | 5.3% | Dec 31, 2023 | 2y |
| KCK LTD. | SGHT Sight Sciences, Inc. | 13G/A | 9.5% | Dec 31, 2023 | 2y |
| Divesh Makan | BRZE Braze, Inc. | 13G/A | 15.8% | Dec 31, 2023 | 2y |
| TURTLE CREEK ASSET MANAGEMENT INC. | URBN Urban Outfitters Inc | 13G/A | 2.5% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | ESE Esco Technologies Inc | 13G/A | 6.6% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | HRTX Heron Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Pentwater Capital Management LP | MANU Manchester United plc | 13G | 8.1% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | ETNB 89bio, Inc. Common Stock | 13G/A | 2.1% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | SPRB Spruce Biosciences, Inc. | 13G | 5.48% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | VALN Valneva SE | 13G/A | 5.42% | Dec 31, 2023 | 2y |
| Mark N. Tompkins | SERV Serve Robotics Inc. | 13G/A | 7.4% | Dec 31, 2023 | 2y |
| Fourthstone LLC | TSBK Timberland Bancorp Inc | 13G/A | 0.83% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | BFAM Bright Horizons Family Solutions Inc. | 13G | 6.5% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | IMUX Immunic, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| William G. Shipley | LEGH Legacy Housing Corp | 13G/A | 11.9% | Dec 31, 2023 | 2y |
| GREENLIGHT CAPITAL INC | COYA Coya Therapeutics, Inc. | 13G/A | 8.8% | Dec 31, 2023 | 2y |
| CVI Investments, Inc. | XMAX XMax Inc. | 13G/A | 4.3% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | 13G | 5.1% | Dec 31, 2023 | 2y |
| RGM Capital, LLC | VRNT Verint Systems Inc | 13G | 5.03% | Dec 31, 2023 | 2y |
| Granahan Investment Management, LLC | BMRA Biomerica Inc | 13G/A | 6.44% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | PTC Ptc Inc. | 13G | 8.1% | Dec 31, 2023 | 2y |